2003
DOI: 10.1128/jvi.77.10.5877-5888.2003
|View full text |Cite
|
Sign up to set email alerts
|

Role of the Serine-Threonine Kinase PAK-1 in Myxoma Virus Replication

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
81
1

Year Published

2005
2005
2018
2018

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 73 publications
(88 citation statements)
references
References 50 publications
6
81
1
Order By: Relevance
“…We constructed an ALVAC-YFP vector that expresses the enhanced yellow fluorescent protein (EYFP) under the control of a vaccinia virus synthetic early/late promoter (VVsynE/L). The rabbit leporipoxvirus myxoma-GFP expresses the enhanced green fluorescent protein (EGFP) under the control of the VVsynE/L promoter as previously described (Opgenorth et al 1992;Johnston et al 2003). The vaccinia virus VV-65 expresses b-galactosidase under the vaccinia early/late promoter p7.5 as previously described (Chakrabarti et al 1997).…”
Section: Methodsmentioning
confidence: 99%
“…We constructed an ALVAC-YFP vector that expresses the enhanced yellow fluorescent protein (EYFP) under the control of a vaccinia virus synthetic early/late promoter (VVsynE/L). The rabbit leporipoxvirus myxoma-GFP expresses the enhanced green fluorescent protein (EGFP) under the control of the VVsynE/L promoter as previously described (Opgenorth et al 1992;Johnston et al 2003). The vaccinia virus VV-65 expresses b-galactosidase under the vaccinia early/late promoter p7.5 as previously described (Chakrabarti et al 1997).…”
Section: Methodsmentioning
confidence: 99%
“…Grb2 participates in the Ras signaling cascade, associating with the guanine nucleotide exchange factor Sos, and thus may link signaling effectors to the MAP kinase pathway. This activation of the MAPK pathway appears to be virus-specific, since U0126, a MAPK/Erk1,2 inhibitor, has been shown to attenuate VACV infection, but increase myxoma virus replication in permissive 3T3 cell lines (314). It has also been demonstrated that HGF/c-Met engagement triggers ERK activation (324,325).…”
Section: In Vitro Vacv Infectionmentioning
confidence: 98%
“…In recent years accumulating evidence suggests that poxviral replication requires the manipulation of target cells in the context of activation of signaling pathways (314,416). In chapter 2 we provide evidence for VACV activation of the chemokine receptor, CCR5, and the phosphorylation-activation of a number of signaling effectors.…”
Section: In Vitro Vacv Infectionmentioning
confidence: 99%
See 2 more Smart Citations